Screening for Epstein–Barr virus (EBV) infection status in university freshmen: acceptability of a gingival swab method

Prophylactic vaccines against Epstein–Barr virus (EBV) are under development. EBV-naïve college freshmen are ideal candidates for an efficacy trial, because their incidence of infectious mononucleosis (mono) during freshman year is as high as 20%. To assess perceptions about mono and a mono vaccine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimm-Geris, J. M., Dunmire, S. K., Duval, L. M., Filtz, E. A., Leuschen, H. J., Schmeling, D. O., Kulasingam, S. L., Balfour, H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518790/
https://www.ncbi.nlm.nih.gov/pubmed/30869049
http://dx.doi.org/10.1017/S0950268819000335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518790/
https://www.ncbi.nlm.nih.gov/pubmed/30869049
http://dx.doi.org/10.1017/S0950268819000335

Ejemplares similares